summary
Introduced
01/09/2017
01/09/2017
In Committee
04/27/2017
04/27/2017
Crossed Over
Passed
Dead
07/07/2017
07/07/2017
Introduced Session
2017 Legislative Measures
Bill Summary
Creates Oregon Premium Protection Program in Department of Consumer and Business Services and establishes Oregon Premium Protection Fund. Requires pharmaceutical manufacturer to pay to department cost of prescription drug that exceeds specified threshold. Requires department to use payments to reimburse insurers, third party administrators, Public Employees' Benefit Board, Oregon Educators Benefit Board, health care service contractors and multiple employer welfare arrangements for incurred costs of drug that exceeds specified threshold. Requires pharmaceutical manufacturer to provide 60 days' advance notice of increase in cost of prescription drug that exceeds 3.4 percent over 12-month period. Prohibits Public Employees' Benefit Board, Oregon Educators Benefit Board, health care service contractors, multiple employer welfare arrangements and carriers for small employer, group or individual health benefit plans from requiring enrollees to incur out-of-pocket costs for prescription drugs that exceed specified maximums. Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services specified information about prescription drug costs and about patient assistance programs. Authorizes civil penalties for failing to report or to make payments required by Oregon Premium Protection Program. Requires Public Employees' Benefit Board, Oregon Educators Benefit Board, health care service contractors, multiple employer welfare arrangements and carriers for small employer, group or individual health benefit plans to make available online specified information about prescription drug coverage and costs and to post to website 30 days' advance notice of termination of coverage of prescription drug.
AI Summary
This bill creates the Oregon Premium Protection Program in the Department of Consumer and Business Services to reduce the burden on consumers and insurers of excessive prescription drug costs. The program requires pharmaceutical manufacturers to pay rebates to the department based on the excess costs incurred by payers, which the department then uses to reimburse payers. The bill also limits the out-of-pocket costs that payers can require enrollees to pay for prescription drugs, requires manufacturers to report on drug pricing and patient assistance programs, and imposes civil penalties for noncompliance. Additionally, the bill amends existing laws to apply these provisions to public employee benefit plans, small employer and group health plans, and individual health plans.
Committee Categories
Budget and Finance, Health and Social Services
Sponsors (0)
No sponsors listed
Last Action
In committee upon adjournment. (on 07/07/2017)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...